Proliferation News and Research

RSS

A new method to distinguish benign and cancerous skin moles

A new study has reported a cost-effective, more accurate, and less invasive way to diagnose cancerous melanoma cells in skin tumors.

30 Sep 2019

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

30 Sep 2019

Human aging processes may hinder cancer development, study finds

A new study, published in Aging Cell, has found that human aging processes may hinder cancer development.

27 Sep 2019

Toxin may play key role in promoting transmission of deadly E. coli strains in cattle

Shiga toxin subtype 2a (Stx2a) may play a key role in promoting the colonization and transmission of life-threatening Escherichia coli strains in cattle, according to a study published October 3 in the open-access journal PLOS Pathogens by Tom McNeilly of the Moredun Research Institute, David Gally of the University of Edinburgh, and colleagues.

From PLOS ONE 27 Sep 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

Researchers explore risk of ALL in children with Down syndrome

Acute lymphoblastic leukemia (ALL), is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL than children without Down syndrome.

24 Sep 2019

Alzheimer’s drug an interesting candidate for the treatment of parasitic Chagas disease

Researchers have discovered that an Alzheimer's drug could serve as a starting point in treating Chagas disease.

20 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Anti-cancer protein promotes tumor resistance, shows study

Areas of solid tumors that have limited access to oxygen, a condition called hypoxia, are highly resilient against chemo and radiation therapy.

20 Sep 2019

Zylka lab receives NIH grant to advance treatments for neurodevelopmental disorders

The National Institutes of Health have awarded two separate grants totaling $6.1 million to Mark Zylka, PhD, director of the UNC Neuroscience Center. One of the grants was co-awarded to Ben Philpot, PhD, associate director of the center at the UNC School of Medicine.

18 Sep 2019

Proliferation News and Research

A new method to distinguish benign and cancerous skin moles

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Human aging processes may hinder cancer development, study finds

Toxin may play key role in promoting transmission of deadly E. coli strains in cattle

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Researchers explore risk of ALL in children with Down syndrome

Alzheimer’s drug an interesting candidate for the treatment of parasitic Chagas disease

Mitochondrial fission factor could represent a promising target for cancer therapy

Anti-cancer protein promotes tumor resistance, shows study

Zylka lab receives NIH grant to advance treatments for neurodevelopmental disorders

CRISPR may explain why so many experimental cancer drugs fail

Promising new drug being developed for polycystic kidney disease

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Novel protein biomarker can help improve dementia risk prediction

Researchers discover a molecule that regulates tumor development in different types of cancers

Scientists find receptor protein in the brain that promotes stress resilience

Breast cancer gene could be key to developing targeted therapy for hepatoblastoma

Hyperactive signaling pathway blocks cell division in the aging brain

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News